Methods for the identification of ikkalpha function and other genes useful for treatment of inflammatory diseases
CA 2485184 A1 · Owner: Marcu, Kenneth · Inventors: Li, Xiang; Marcu, Kenneth; Peet, Gregory
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a method for identifying genes involved in the NF- .kappa.B pathway comprised of the steps of determining the level of expression of a gene in an experimental sample obtained from the cells having deficient levels of a component of the NF-.kappa.B pathway; determining the level of expression of said gene in a control sample obtained from wild type cells having levels of a component of a biological pathway; selecting genes having a level of expression that are modulated in said experimental sample relative to said wild type sample. The invention also provides a method of treating inflammatory related diseases by modulating the activity of IKK.alpha..
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 23, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 23, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 23, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.